Article Versions Notes

Onyido EK, James D, Garcia-Parra J, Sinfield J, Moberg A, Coombes Z, Worthington J, Williams N, Francis LW, Conlan RS, et al. Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity. Antibodies. 2023; 12(4):65. https://doi.org/10.3390/antib12040065

Onyido, Emenike Kenechi, David James, Jezabel Garcia-Parra, John Sinfield, Anna Moberg, Zoe Coombes, Jenny Worthington, Nicole Williams, Lewis Webb Francis, Robert Steven Conlan, and et al. 2023. "Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity" Antibodies 12, no. 4: 65. https://doi.org/10.3390/antib12040065

Onyido, E. K., James, D., Garcia-Parra, J., Sinfield, J., Moberg, A., Coombes, Z., Worthington, J., Williams, N., Francis, L. W., Conlan, R. S., & Gonzalez, D. (2023). Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity. Antibodies, 12(4), 65. https://doi.org/10.3390/antib12040065